RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Biogend Therapeutics Co Stock

Biogend Therapeutics Co P/E 2024

Biogend Therapeutics Co P/E

-45.38

Ticker

6733.TWO

ISIN

TW0006733009

As of Nov 12, 2024, Biogend Therapeutics Co's P/E ratio was -45.38, a 38.44% change from the -32.78 P/E ratio recorded in the previous year.

The Biogend Therapeutics Co P/E history

Biogend Therapeutics Co Aktienanalyse

What does Biogend Therapeutics Co do?

Biogend Therapeutics Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Biogend Therapeutics Co's P/E Ratio

The Price to Earnings (P/E) Ratio of Biogend Therapeutics Co is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Biogend Therapeutics Co's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Biogend Therapeutics Co is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Biogend Therapeutics Co’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Biogend Therapeutics Co stock

What is the price-to-earnings ratio of Biogend Therapeutics Co?

The price-earnings ratio of Biogend Therapeutics Co is currently -45.38.

How has the price-earnings ratio of Biogend Therapeutics Co changed compared to last year?

The price-to-earnings ratio of Biogend Therapeutics Co has increased by 38.44% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Biogend Therapeutics Co high compared to other companies?

Yes, the price-to-earnings ratio of Biogend Therapeutics Co is high compared to other companies.

How does an increase in the price-earnings ratio of Biogend Therapeutics Co affect the company?

An increase in the price-earnings ratio of Biogend Therapeutics Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Biogend Therapeutics Co affect the company?

A decrease in the price-earnings ratio of Biogend Therapeutics Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Biogend Therapeutics Co?

Some factors that influence the price-earnings ratio of Biogend Therapeutics Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Biogend Therapeutics Co pay?

Over the past 12 months, Biogend Therapeutics Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biogend Therapeutics Co is expected to pay a dividend of 0 TWD.

What is the dividend yield of Biogend Therapeutics Co?

The current dividend yield of Biogend Therapeutics Co is .

When does Biogend Therapeutics Co pay dividends?

Biogend Therapeutics Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biogend Therapeutics Co?

Biogend Therapeutics Co paid dividends every year for the past 0 years.

What is the dividend of Biogend Therapeutics Co?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biogend Therapeutics Co located?

Biogend Therapeutics Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biogend Therapeutics Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biogend Therapeutics Co from 11/12/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 11/12/2024.

When did Biogend Therapeutics Co pay the last dividend?

The last dividend was paid out on 11/12/2024.

What was the dividend of Biogend Therapeutics Co in the year 2023?

In the year 2023, Biogend Therapeutics Co distributed 0 TWD as dividends.

In which currency does Biogend Therapeutics Co pay out the dividend?

The dividends of Biogend Therapeutics Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biogend Therapeutics Co

Our stock analysis for Biogend Therapeutics Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biogend Therapeutics Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.